Open Access

Venous thrombosis in patients after catheter ablation.Efficacy and safety of enoxaparin therapy with the transition to warfarin and monotherapy with rivaroxaban

Congress Session

About the speaker

Miss Anastasia Loginova

Cardiology Research and Production Center, Moscow (Russian Federation)
0 follower

6 more presentations in this session

Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease.

Speaker: Doctor A. Tarasov (Moscow, RU)

Thumbnail

Effect of efficient lipid-lowering atorvastatin therapy on heart rate variability in the post-infarction period

Speaker: Professor V. Oleinikov (Penza, RU)

Thumbnail

QT dispersion in patients with myocardial infarction and high-dose therapy with atorvastatin

Speaker: Professor V. Oleinikov (Penza, RU)

Thumbnail

Antiarrhythmic relevance of inhibiting cardiac and non-cardiac sodium channel isoforms for the suppression of torsades de pointes arrhythmias in the chronic av block dog

Speaker: Mr A. Bossu (Utrecht, NL)

Thumbnail

Analysis of predictive factors for propafenone proarrythmia. Does exercise ECG play a role during long term propafenone treatment?

Speaker: Mr P. Kalmar (Debrecen, HU)

Thumbnail

Access the full session

Poster session 2 - Arrhythmias

Speakers: Miss A. Loginova, Doctor A. Tarasov, Professor V. Oleinikov, Professor V. Oleinikov, Mr A. Bossu...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk